<DOC>
	<DOCNO>NCT00704132</DOCNO>
	<brief_summary>A clinical study determine safety , efficacy way sitagliptin work patient Type 2 Diabetes Mellitus inadequate glycemic ( blood sugar ) control .</brief_summary>
	<brief_title>Sitagliptin Mechanism Action Study Patients With Type 2 Diabetes Mellitus ( 0431-059 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Participant type 2 diabetes mellitus Males Females highly unlikely become pregnant Participants poorly control without take , take one two oral antidiabetic medication Participant history type 1 diabetes mellitus history ketoacidosis Participant require insulin therapy within prior 8 week Participant take TZDs Actos® ( pioglitazone ) Avandia® ( rosiglitazone ) within prior 12 week screen visit</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>